REal World Data in LYmphoma and Survival in Adults
Recruiting now
Conditions studied: Diffuse Large B Lymphoma (DLBCL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL), T-cell Lymphoma (T-NHL), Hodgkin's Lymphoma (HL), Burkitt Lymphoma (BL))
In brief
REALYSA cohort is a population-based epidemiological platform in real-life for lymphomas designed to enrich prognostic data, by integrating together epidemiological, clinical and biological data. REALYSA is a platform perfectly set up to * Study prognostic factors using integrated epidemiological and biological data (genetics), to better characterize the determinants of refractoriness and relapse in patients with lymphoma, to follow the growing number of survivors and describe median to long-term sequela, second cancer, quality of life (QoL)… * Document treatment effectiveness in real life and observance * Address socio-economical questions
Key facts
- Study ID
- NCT03869619
- Run by
- Hospices Civils de Lyon
- People needed
- 6000
- Starts
- 2018-11-14
- Expected to finish
- 2027-11-14
- Last updated by the study team
- 2021-06-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Signature of the consent form for participation in the REALYSA cohort
- Aged over 18 at the time of inclusion
- Diagnosed with lymphoma in the last 6 months (180 days)
- Lymphoma subtype belonging to at least one of the 7 histological subtypes: diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, marginal zone lymphoma, T-cell lymphoma, Hodgkin's lymphoma, Burkitt lymphoma
You may not qualify if…
- Anti-lymphoma treatment already received (except pre-phase: typically corticosteroids, vincristine, cyclophosphamide, etoposide, alone or in combination)
- Documented HIV infection
- Any other lymphoma subtype not included in the list in Appendix 1. Of note, are excluded:
- Chronic lymphocytic leukemia/small lymphocytic lymphoma
- Hairy cell leukemia and variant
- Lymphoplasmacytic lymphoma
- Waldenström macroglobulinemia
- Primary DLBCL of the central nervous system (CNS)
- T-cell large granular lymphocytic leukemia
- Chronic lymphoproliferative disorder of NK cells
- Mycosis fungoides
- Sézary syndrome
- Primary cutaneous T cell lymphomas (mainly diagnosed and treated by dermatologists)
- Post-transplant lymphoproliferative disorders (PTLD)
Where it is running
- Unité d'Hématologie Clinique, CH D'ARRAS — Arras, France (enrolling)
- Service d'Hématologie, CHU Jean Minjoz — Besançon, France (enrolling)
- Service d'Onco-radiolothérapie, Polyclinique Bordeaux Nord Aquitaine — Bordeaux, France (enrolling)
- Institut Bergonié — Bordeaux, France (enrolling)
- Centre Hospitalier Pierre Oudot — Bourgoin, France (enrolling)
- Service d'Hématologie, Institut d'Hématologie de Basse Normandie — Caen, France (enrolling)
- METROPOLE SAVOIE - SITE CHAMBERY, place Lucien Biset, — Chambéry, France (enrolling)
- Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Estaing, CHU de Clermont-Ferrand — Clermont-Ferrand, France (enrolling)
- Unité Hémopathies Lymphoïdes, Hôpital Henri Mondor — Créteil, France (enrolling)
- CHU Francois MITTERRAND — Dijon, France (enrolling)
- Service Hématologie, Centre Hospitalier de Dunkerque — Dunkirk, France (enrolling)
- Service Oncologie médicale, Groupe Hospitalier Mutualiste de Grenoble, Institut Daniel Hollard, — Grenoble, France (enrolling)
- CHD Vendée — La Roche-sur-Yon, France (enrolling)
- Service d'Hématologie Clinique, Centre Hospitalier Universitaire Michallon — La Tronche, France (enrolling)
- Clinique Victor Hugo — Le Mans, France (enrolling)
- Centre hospitalier Libourne — Libourne, France (enrolling)
- Service Oncologie médicale, HOPITAL SAINT VINCENT-DE-PAUL — Lille, France (enrolling)
- Service des maladies du sang, Hôpital Claude Huriez, CHRU de Lille — Lille, France (enrolling)
- Service Hématologie Clinique et Thérapie Cellulaire, CHU DE LIMOGES - HOPITAL DUPUYTREN, — Limoges, France (enrolling)
- Département d'Hématologie et Oncologie, Centre Léon Bérard — Lyon, France (enrolling)
- Département d'Hématologie Clinique, Hôpital Saint-Eloi, — Montpellier, France (enrolling)
- Service Hématologie, GH REGION MULHOUSE ET SUD ALSACE - HOPITAL EMILE MULLER, — Mulhouse, France (enrolling)
- Service d'Hématologie clinique, Centre Hospitalier Universitaire de Nantes — Nantes, France (enrolling)
- Centre Hospitalier de Niort — Niort, France (enrolling)
- Service Hématologie, Hôpital St Louis — Paris, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.